Opko Health (OPK) Shares Outstanding (2010 - 2026)
Opko Health's (OPK) quarterly Shares Outstanding (Entity) came in at $776.1 million in Q2 2026, down 4.13% YoY from $809.6 million in Q2 2025, and down 1.12% on a QoQ basis from $784.9 million in Q1 2026.
Opko Health (OPK) Shares Outstanding (2010 - 2026) Analysis & Trends
Opko Health (OPK) has 17 years of Shares Outstanding (Entity) data on file, last reported at $776.1 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) fell 4.13% year-over-year to $776.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $776.1 million (down 4.13% YoY) and the FY2025 annual result came in at $789.9 million, up 12.63% from the prior year.
- Shares Outstanding (Entity) declined to $776.1 million in Q2 2026, from $784.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $809.6 million in Q2 2025 to a low of $690.1 million in Q1 2022.
- A 5-year average of $760.5 million and a median of $781.3 million in 2022 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) rose 13.24% — and 2024, when it dropped 10.31%.
- Tracing OPK's Shares Outstanding (Entity) over 5 years: stood at $781.3 million in 2022, then grew by 0.08% to $781.9 million in 2023, then decreased by 10.31% to $701.4 million in 2024, then advanced by 12.63% to $789.9 million in 2025, then fell by 1.75% to $776.1 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $776.1 million (Q2 2026), $784.9 million (Q1 2026), and $789.9 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 371.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 705.30 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 143.28 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 282.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 166.10 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 78.95 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 151.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 20.12 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 81.70 Mn |
| 10 | Opko Health | 1.13 Bn | 824.59 Mn | 80.02 Mn | 755.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 755.27 Mn |
| Mar 31, 2026 | 758.88 Mn |
| Dec 31, 2025 | 751.13 Mn |
| Sep 30, 2025 | 777.15 Mn |
| Jun 30, 2025 | 788.01 Mn |
| Mar 31, 2025 | 671.58 Mn |
| Dec 31, 2024 | 694.02 Mn |
| Sep 30, 2024 | 694.62 Mn |
| Jun 30, 2024 | 697.21 Mn |
| Mar 31, 2024 | 706.88 Mn |
| Dec 31, 2023 | 751.77 Mn |
| Sep 30, 2023 | 751.53 Mn |
| Jun 30, 2023 | 751.73 Mn |
| Mar 31, 2023 | 751.51 Mn |
| Dec 31, 2022 | 719.06 Mn |
| Sep 30, 2022 | 750.40 Mn |
| Jun 30, 2022 | 712.55 Mn |
| Mar 31, 2022 | 660.30 Mn |
| Dec 31, 2021 | 648.08 Mn |
| Sep 30, 2021 | 651.84 Mn |